Mucinous colorectal cancer has, in the past, been associated with inferior responses to treatment, and worse patient outcomes compared with other colorectal cancer subtypes; although, this situation has improved in the past 10–15 years. In this Review, the authors describe the key developments that have enabled these improvements, in addition to the potential for further improvements in the care of patients with mucinous colorectal cancer.
- Niek Hugen
- Gina Brown
- Iris D. Nagtegaal
